© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#triple-negative breast cancer
Trodelvy Improves Survival and Quality of Life for People With Triple-Negative Breast Cancer
3D rendering of the breast
Immunotherapy Improves Triple-Negative Breast Cancer Survival
October is Breast Cancer Awareness Month
Breast Cancer 101

Substantial Racial and Ethnic, Geographic Disparities in Triple Negative Breast Cancer Rates

Researchers stress funding breast cancer research to include representation of racially and ethnically diverse populations

Is Immunotherapy the Only Cancer Treatment Some People Need?

Immunotherapy and … nothing else? Studies test a potential paradigm shift in treatment for some people with early stage cancers.
October is Breast Cancer Awareness Month

National Breast Cancer Awareness Month

An annual campaign to increase awareness of the disease.

Keytruda Improves Survival in Advanced Triple-Negative Breast Cancer

Compared with chemotherapy alone, adding immunotherapy drug Keytruda helped triple-negative breast cancer patients live longer.

New Biomarker Classification May Improve Treatment of High-Risk Breast Cancer

The new cancer subtypes help better characterize a person’s tumor. The goal is to get the right drug to the right patient.
Eileen Z. Fuentes

Cancer Health 25: Eileen Z. Fuentes

A cancer survivor turned health justice activist who helps other people with cancer navigate the confusing medical system

When Breast Cancer Spreads to the Brain: What You Need to Know

A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.
3D rendering of the breast

Cleveland Clinic Launches First-of-its-Kind Preventive Triple-Negative Breast Cancer Vaccine Study

A novel clinical trial based on research from Cleveland Clinic’s Lerner Research Institute targets triple-negative breast cancer.

New Role Discovered for Mutant Protein Found in Most Breast Cancers

An estrogen receptor known as ERα plays a critical role in more than 70% of breast cancers.

Immunotherapy for Early Breast Cancer

The Food and Drug Administration recently approved the checkpoint inhibitor Keytruda (pembrolizumab).

FDA Reconsiders Accelerated Approvals of Immunotherapy Drugs

An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.

Hot topics

Breast cancer self check
#metastatic breast cancer
Breast Cancer Support Groups

Statins Could Improve Outcomes for People With Triple-Negative Breast Cancer

Overall survival increased by 30% among women with aggressive breast cancer who began statin use post-diagnosis.

FDA Approves Keytruda for Pre- and Post-Surgery Treatment of Early Triple-Negative Breast Cancer

This is the first immunotherapy approved for previously untreated triple-negative breast cancer that is likely to relapse.

Keytruda

Lynparza Follow-Up Treatment Delays Breast Cancer Recurrence

PARP inhibitor reduces the risk of disease recurrence in BRCA-positive people with high-risk early breast cancer.
3D rendering of the breast

FDA Approves Trodelvy for Triple-Negative Breast Cancer

The antibody-drug conjugate is the second drug approved for metastatic breast cancer in the course of a week.
Advertisement
Science News
Features

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.